Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02317991
Title Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer
Recruitment Completed
Phase Phase II
Variant Requirements No
Sponsors SCRI Development Innovations, LLC
Age Groups:
Covered Countries USA

Facility Status City State Zip Country Details
Rocky Mountain Cancer Centers Denver Colorado 80218 United States Details
Florida Cancer Specialists-South Fort Myers Florida 33916 United States Details
Florida Hospital Cancer Institute Orlando Florida 32804 United States Details
Florida Cancer Specialists-North Saint Petersburg Florida 33705 United States Details
Ingalls Cancer Research Center Harvey Illinois 60425 United States Details
Research Medical Center Kansas City Missouri 64132 United States Details
Oncology Hematology Care Cincinnati Ohio 45242 United States Details
Spartanburg Medical Center/Gibbs Cancer Center Spartanburg South Carolina 29303 United States Details
Tennessee Oncology Chattanooga Tennessee 37404 United States Details
Tennessee Oncology PLLC Nashville Tennessee 37203 United States Details
Center for Cancer and Blood Disorders Fort Worth Texas 76104 United States Details
*Shaded cells indicate that there was no data available from for the field